Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,712 public trials 267 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

7-week Study With CT-155 in People With Schizophrenia

NCT05486312

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • CT-155 Study Center Culver City, California, United States
  • CT-155 Study Center Garden Grove, California, United States
  • CT-155 Study Center La Habra, California, United States
  • CT-155 Study Center San Bernardino, California, United States
View Trial Details
Completed

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

NCT02431702

Conditions
Mental Disorders, Psychotic Disorders, Schizophrenia, +1 more
Locations
  • Little Rock, Arkansas, United States
  • Garden Grove, California, United States
  • Lemon Grove, California, United States
  • Los Angeles, California, United States
View all 38 locations
View Trial Details
Completed

A Study of Paliperidone Palmitate 6-Month Formulation

NCT04072575

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Fundacion para el Estudio y Tratamiento de las Enfermedades Mentales Buenos Aires, Argentina
  • CEN Consultorios Especializados en Neurociencias Córdoba, Argentina
  • Sanatorio Prof. Leon S. Morra Córdoba, Argentina
  • INSA Instituto de Neurociencias San Agustín La Plata, Argentina
View all 30 locations
View Trial Details
Completed

A Study of Paliperidone Palmitate 6-Month Formulation

NCT03345342

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Woodland Research Northwest Rogers, Arkansas, United States
  • California Pharmaceutical Research Institute, Inc. Anaheim, California, United States
  • ATP Clinical Research Costa Mesa, California, United States
  • Collaborative NeuroScience Network Garden Grove, California, United States
View all 138 locations
View Trial Details
Completed

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

NCT03809325

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Chu Brugmann Brussels, Belgium
  • Centre Médico Psychologique De Courbevoie Asnières-sur-Seine, France
  • Centre Medico Psychologique Cagnes-sur-Mer, France
  • Cabinet medical Dax, France
View all 41 locations
View Trial Details
Completed

A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

NCT04940039

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • University Teaching Hospital of Butare(CHUB) Butare, Rwanda
  • Kibuye Referral Hospital Kibuye, Rwanda
  • CARAES Ndera Neuro-Psychiatric Hospital Kigali, Rwanda
  • University Teaching Hospital of Kigali Kigali, Rwanda
View Trial Details

Related conditions